1. A case of non-neutropenic invasive pulmonary aspergillosis under immune checkpoint inhibitor therapy for malignant melanoma. (2022) Authors: Uchida, Yoshinori; Shimamura, So; Ide, Shuichiro; Masuda, Kazuki; Saiki, Masafumi; Sogami, Yusuke; Ishihara, Hiroshi Journal: Respiratory medicine case reports Issue: Volume 37(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Barcode sequencing identifies resistant mechanisms to epidermal growth factor receptor inhibitors in circulating tumor DNA of lung cancer patients. Issue 10 (19th August 2019) Authors: Kitazono, Satoru; Sakai, Kazuko; Yanagitani, Noriko; Ariyasu, Ryo; Yoshizawa, Takahiro; Dotsu, Yosuke; Koyama, Junji; Saiki, Masafumi; Sonoda, Tomoaki; Nishikawa, Shingo; Uchibori, Ken; Horiike, Atsushi; Nishio, Kazuto; Nishio, Makoto Journal: Cancer science Issue: Volume 110:Issue 10(2019) Page Start: 3350 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical efficacy of amrubicin in patients with small cell lung cancer relapse after first‐line treatment including immune checkpoint inhibitors: A retrospective multicenter study (TOPGAN 2021‐01). Issue 2 (21st November 2022) Authors: Uematsu, Shinya; Kitazono, Satoru; Tanaka, Hisashi; Saito, Ryota; Kawashima, Yosuke; Ohyanagi, Fumiyoshi; Tozuka, Takehiro; Ryosuke, Tsugitomi; Sakatani, Toshio; Horiike, Atsushi; Yoshizawa, Takahiro; Saiki, Masafumi; Tambo, Yuichi; Koyama, Junji; Kanazu, Masaki; Kudo, Keita; Tsuchiya‐Kawano, Yuk... Journal: Thoracic cancer Issue: Volume 14:Issue 2(2023) Page Start: 168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Correlation between serum adenosine deaminase activity and efficacy of anti-programmed cell death-1 antibody. (July 2019) Authors: Saiki, Masafumi; Yoshizawa, Takahiro; Dotsu, Yosuke; Ariyasu, Ryo; Koyama, Junji; Sonoda, Tomoaki; Uchibori, Ken; Nishikawa, Shingo; Kitazono, Satoru; Yanagitani, Noriko; Horiike, Atsushi; Nishio, Makoto Journal: Lung cancer Issue: Volume 133(2019) Page Start: 4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Dramatic response to alectinib in an ALK‐positive LCNEC patient with a poor performance status: A case report. Issue 9 (3rd August 2021) Authors: Masuda, Kazuki; Saiki, Masafumi; Shimamura, So; Ide, Shuichiro; Uchida, Yoshinori; Sogami, Yusuke; Ishihara, Hiroshi; Ikeda, Fumi; Kugiyama, Kiyotaka Journal: Respirology case reports Issue: Volume 9:Issue 9(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. EGFR T790M mutation after chemotherapy for small cell lung cancer transformation of EGFR-positive non-small cell lung cancer. (2018) Authors: Sonoda, Tomoaki; Nishikawa, Shingo; Sakakibara, Rie; Saiki, Masafumi; Ariyasu, Ryo; Koyama, Junji; Kitazono, Satoru; Yanagitani, Noriko; Horiike, Atsushi; Ohyanagi, Fumiyoshi; Ninomiya, Hironori; Ishikawa, Yuichi; Nishio, Makoto Journal: Respiratory medicine case reports Issue: Volume 24(2018) Page Start: 19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. High ratio of T790M to EGFR activating mutations correlate with the osimertinib response in non-small-cell lung cancer. (March 2018) Authors: Ariyasu, Ryo; Nishikawa, Shingo; Uchibori, Ken; Oh-hara, Tomoko; Yoshizawa, Takahiro; Dotsu, Yosuke; Koyama, Junji; Saiki, Masafumi; Sonoda, Tomoaki; Kitazono, Satoru; Yanagitani, Noriko; Horiike, Atsushi; Inase, Naohiko; Kasahara, Kazuo; Nishio, Makoto; Katayama, Ryohei Journal: Lung cancer Issue: Volume 117(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Improvement in the survival of patients with stage IV non-small-cell lung cancer: Experience in a single institutional 1995–2017. (May 2019) Authors: Takano, Natsuki; Ariyasu, Ryo; Koyama, Junji; Sonoda, Tomoaki; Saiki, Masafumi; Kawashima, Yosuke; Oguri, Tomoyo; Hisakane, Kakeru; Uchibori, Ken; Nishikawa, Shingo; Kitazono, Satoru; Yanagitani, Noriko; Ohyanagi, Fumiyoshi; Horiike, Atsushi; Gemma, Akihiko; Nishio, Makoto Journal: Lung cancer Issue: Volume 131(2019) Page Start: 69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Myositis induced by durvalumab in a patient with non‐small cell lung cancer: A case report. Issue 12 (26th October 2020) Authors: Kobayashi, Miyuki; Saiki, Masafumi; Omori, Chisa; Ide, Shuichiro; Masuda, Kazuki; Sogami, Yusuke; Hata, Takanori; Ishihara, Hiroshi Journal: Thoracic cancer Issue: Volume 11:Issue 12(2020) Page Start: 3614 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Significant therapeutic effectiveness of durvalumab after chemoradiotherapy for a patient with post‐operative recurrent pulmonary pleomorphic carcinoma. Issue 6 (11th May 2021) Authors: Shimamura, So; Saiki, Masafumi; Ide, Shuichiro; Masuda, Kazuki; Uchida, Yoshinori; Sogami, Yusuke; Kasai, Kazunari; Inoue, Tomohiro; Ishihara, Hiroshi Journal: Respirology case reports Issue: Volume 9:Issue 6(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗